0
0
Home » Pharmaceuticals » Therapy Area » Genito Urinary System And Sex Hormones

Chronic Kidney Disease Epidemiology Analysis and Forecast, 2021-2031

The total prevalent cases of chronic kidney disease (CKD) were 103,485,844 cases in 2021 in the 7 major markets (7MM). The number of cases is expected to increase at an annual growth rate (AGR) of more than 1% during the forecast period. Chronic kidney disease or chronic renal disease, is a condition characterized by a gradual loss of kidney function over time. This leads to the accumulation of excess fluid and waste in the body. In the early stages, chronic kidney disease is a largely asymptomatic condition. As the disease progresses, the symptoms worsen and eventually lead to kidney failure.

The chronic kidney disease market research report provides an overview of the risk factors, comorbidities, and global and historical trends for CKD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It also includes a 10-year epidemiological forecast for total prevalent cases and diagnosed prevalent cases of CKD. The total and diagnosed prevalent cases of CKD are further segmented by age, sex, and stage in these markets.

Chronic Kidney Disease Market Overview

Chronic Kidney Disease Market Overview

To gain more information on the chronic kidney disease market forecast, download a free report sample

What are the key age segments in the chronic kidney disease market?

The chronic kidney disease market can be segmented based on age into 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.

In 2021, for the 7MM combined, adults ages 70–79 years contributed the highest proportion of the diagnosed prevalent cases of chronic kidney disease followed by the age group 60–69 years and ages 80 years and older.

Chronic Kidney Disease Market Analysis by Age

Chronic Kidney Disease Market Analysis by Age

For more age segment insights, download a free report sample

What are the key sex segments in the chronic kidney disease market?

The chronic kidney disease market can be segmented based on sex into men and women.

In the 7MM combined, the number of diagnosed prevalent cases of CKD was higher in women than in men in 2021. However, in Germany and Japan, the number of diagnosed prevalent cases of CKD was observed to be higher in men than in women. France had the smallest variation in the number of diagnosed prevalent cases between men and women.

Chronic Kidney Disease Market Analysis by Sex

Chronic Kidney Disease Market Analysis by Sex

For more sex segment insights, download a free report sample

What are the key stages in the chronic kidney disease market?

The chronic kidney disease market can be further divided into six stages: stage I, stage II, stage IIIa, stage IIIb, stage IV, and stage V.

In the 7MM, the highest number of diagnosed prevalent cases of CKD was in stage IIIa followed by stages IIIb and stage II. Among the 7MM, Japan had the highest number of diagnosed prevalent cases of CKD in stage IIIa followed by the US. This difference in stage-specific diagnosed prevalent cases might be driven by the varying stage-specific diagnosis rate in the markets.

Chronic Kidney Disease Market Analysis by Stages

Chronic Kidney Disease Market Analysis by Stages

For more stage insights, download a free report sample

What are the key dialysis dependence types in the chronic kidney disease market?

The chronic kidney disease market can be divided into two types based on dialysis dependence: non-dialysis dependent and dialysis dependent.

In the 7MM, the US had the highest number of diagnosed prevalent cases of CKD that were non-dialysis dependent followed by Japan and Germany. For dialysis-dependent CKD, the US had the highest number of diagnosed prevalent cases followed by Japan and Germany.

Chronic Kidney Disease Market Analysis by Dialysis Dependence

Chronic Kidney Disease Market Analysis by Dialysis Dependence

For more insights on dialysis dependence types, download a free report sample

Which are the 7 major markets (7MM) in the chronic kidney disease market?

The 7 major markets in chronic kidney disease are the US, France, Germany, Italy, Spain, the UK, and Japan.

It is expected that, in 2031, the US will have the highest number of diagnosed prevalent cases of CKD in the 7MM and Italy will have the fewest diagnosed prevalent cases of CKD.

Market Report Scope

Market size (2021) 103,485,844 cases
AGR >1%
Forecast period 2021-2031
7 major markets (7MM) The US, France, Germany, Italy, Spain, the UK, and Japan
Key age segments 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.
Key sex segments Men and Women
Key stage Stage I, Stage II, Stage IIIa, Stage IIIb, Stage IV, And Stage V
Key dialysis dependence types Non-Dialysis Dependent and Dialysis Dependent

Scope

  • The Chronic Kidney Disease Epidemiology Report and Model provide an overview of the risk factors and global trends of CKD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • The report includes a 10-year epidemiological forecast for the total and diagnosed prevalent cases of CKD. The total and diagnosed prevalent cases of CKD are further segmented by age (18 years and older), sex, and stage (stage I, stage II, stage IIIa, stage IIIb, stage IV, and stage V) in these markets. Diagnosed prevalent cases of CKD are further segmented by dialysis-dependent (including both hemodialysis and peritoneal dialysis) and non-dialysis-dependent. The model associated with the report also provides the diagnosed prevalent cases of CKD further segmented by hyperparathyroidism, hyperphosphatemia, and hyperkalemia among dialysis-dependent and non-dialysis-dependent cases.
  • The CKD epidemiology report and model were written and developed by the master- and PhD-level epidemiologists.
  • The epidemiology report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
  • The epidemiology model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to Buy

  • The Chronic Kidney Disease Epidemiology series will allow you to:
  • Develop business strategies by understanding the trends shaping and driving the global CKD market.
  • Quantify patient populations in the global CKD market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for CKD therapeutics in each of the markets covered.
  • Understand the magnitude of CKD population by subtype, digital vasculopathy, and other internal organ involvement.

Table of Contents

| About GlobalData

1 Chronic Kidney Disease: Executive Summary

1.1 Catalyst

1.2 Related Reports

1.3 Upcoming Reports

2 Epidemiology

2.1 Disease Background

2.2 Risk Factors and Comorbidities

2.3 Global and Historical Trends

2.4 7MM Forecast Methodology

2.4.1 Sources

2.4.2 Forecast Assumptions and Methods

2.4.3 Total Prevalent Cases of CKD

2.4.4 Total Prevalent Cases of CKD by Stage

2.4.5 Diagnosed Prevalent Cases of CKD

2.4.6 Diagnosed Prevalent Cases of CKD by Stage

2.4.7 Diagnosed Prevalent Cases of CKD Based on Dialysis Dependence

2.5 Epidemiological Forecast for CKD (2021–31)

2.5.1 Total Prevalent Cases of CKD

2.5.2 Total Prevalent Cases of CKD by Stage

2.5.3 Diagnosed Prevalent Cases of CKD

2.5.4 Age-Specific Diagnosed Prevalent Cases of CKD

2.5.5 Sex-Specific Diagnosed Prevalent Cases of CKD

2.5.6 Diagnosed Prevalent Cases of CKD by Stage

2.5.7 Diagnosed Prevalent Cases of CKD by Dialysis Dependence

2.6 Discussion

2.6.1 Epidemiological Forecast Insight

2.6.2 COVID-19 Impact

2.6.3 Limitations of the Analysis

2.6.4 Strengths of the Analysis

3 Appendix

3.1 Bibliography

3.2 About the Authors

3.2.1 Epidemiologist

3.2.2 Reviewers

3.2.3 Global Director of Therapy Analysis and Epidemiology

3.2.4 Global Head and EVP of Healthcare Operations and Strategy

| Contact Us

List of Tables

Table 1: Summary of updated data types

Table 2: KDIGO classification of CKD

Table 3: Risk factors and comorbid conditions associated with CKD

List of Figures

Figure 1: 7MM, total prevalent cases of CKD, both sexes, N, ages ≥18 years, 2021 and 2031

Figure 2: 7MM, diagnosed prevalent cases of CKD, both sexes, N, ages ≥18 years, 2021 and 2031

Figure 3: 7MM, diagnosed prevalence of CKD (%), men, ages ≥18 years, 2021

Figure 4: 7MM, sources used and not used to forecast the total and diagnosed prevalent cases of CKD

Figure 5: 7MM, sources used to forecast the total prevalent cases of CKD by stage

Figure 6: 7MM, sources used to forecast the diagnosed prevalent cases of CKD by stage

Figure 7: 7MM, sources used to forecast the diagnosed prevalent cases of CKD by dialysis dependence

Figure 8: 7MM, total prevalent cases of CKD, N, both sexes, ages ≥18 years, 2021

Figure 9: 7MM, total prevalent cases of CKD by stage, N, both sexes, ages ≥18 years, 2021

Figure 10: 7MM, diagnosed prevalent cases of CKD, N, both sexes, ages ≥18 years, 2021

Figure 11: 7MM, diagnosed prevalent cases of CKD by age group, N, both sexes, 2021

Figure 12: 7MM, diagnosed prevalent cases of CKD by sex, N, ages ≥18 years, 2021

Figure 13: 7MM, diagnosed prevalent cases of CKD by stage, N, both sexes, ages ≥18 years, 2021

Figure 14: 7MM, diagnosed prevalent cases of CKD by dialysis dependence, N, both sexes, ages ≥18 years, 2021

Figure 15: 7MM, diagnosed prevalent cases of CKD based on dialysis-dependent subtype, N, both sexes, ages ≥18 years, 2021

Frequently Asked Questions

The total prevalent cases of chronic kidney disease were 103,485,844 cases in 2021 in the 7 major markets (7MM).

 

 

 

The chronic kidney disease market is expected to grow at an annual growth rate (AGR) of more than 1% during the forecast period.

The 7 major markets in chronic kidney disease are the US, France, Germany, Italy, Spain, the UK, and Japan.

The chronic kidney disease market can be segmented based on age into 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and above 80 years.

The chronic kidney disease market can be segmented based on sex into men and women.

The chronic kidney disease market can be further divided into six stages: stage I, stage II, stage IIIa, stage IIIb, stage IV, and stage V.

The chronic kidney disease market can be divided into two types based on dialysis dependence: non-dialysis dependent and dialysis dependent.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports